NCT06200220View on ClinicalTrials.gov

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

RecruitingOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

December 28, 2023

Study Completion Date

December 1, 2025

Conditions

Waldenstrom's Macroglobulinaemia Refractory

Interventions

DRUG

Venetoclax

Observational study

Trial Locations (1)

86000

RECRUITING

CHU Poitiers, Poitiers

All Listed Sponsors

lead

Poitiers University Hospital

OTHER